AcelRx Pharmaceuticals
ACRX
#9735
Rank
HK$0.11 B
Marketcap
HK$6.69
Share price
7.50%
Change (1 day)
40.76%
Change (1 year)

Revenue for AcelRx Pharmaceuticals (ACRX)

Revenue in 2023 (TTM): HK$5.09 Million

According to AcelRx Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is HK$5.06 Million. In 2022 the company made a revenue of HK$1.96 Million a decrease over the revenue in the year 2021 that were of HK$21.97 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for AcelRx Pharmaceuticals from 2010 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) HK$5.09 M158.72%
2022 HK$1.96 M-91.04%
2021 HK$21.97 M-47.66%
2020 HK$41.98 M135.52%
2019 HK$17.82 M5.83%
2018 HK$16.84 M-73.03%
2017 HK$62.46 M-53.59%
2016 HK$0.13 B-9.85%
2015 HK$0.14 B268.96%
2014 HK$40.46 M-82.31%
2013 HK$0.22 B1132.83%
2012 HK$18.55 M122.87%
2011 HK$8.32 M
2010 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
HK$85.58 M 1,589.09%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.58 B 11,476.04%๐Ÿ‡บ๐Ÿ‡ธ USA